Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Breakthrough Bloodstream Infections Caused by Echinocandin-Resistant Candida tropicalis: An Emerging Threat to Immunocompromised Patients with Hematological Malignancies.

Sfeir MM, Jiménez-Ortigosa C, Gamaletsou MN, Schuetz AN, Soave R, Besien KV, Small CB, Perlin DS, Walsh TJ.

J Fungi (Basel). 2020 Jan 31;6(1). pii: E20. doi: 10.3390/jof6010020.

2.

Impact of a Multiplexed PCR Panel on Identifying Diarrheal Pathogens in Hematopoietic Cell Transplant Recipients.

Rogers WS, Westblade LF, Soave R, Jenkins SG, van Besien K, Singh HK, Walsh TJ, Small CB, Shore T, Crawford CV, Satlin MJ.

Clin Infect Dis. 2019 Nov 5. pii: ciz1068. doi: 10.1093/cid/ciz1068. [Epub ahead of print]

PMID:
31687767
3.

Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk.

Van Besien K, Bachier-Rodriguez L, Satlin M, Brown MA, Gergis U, Guarneri D, Hsu J, Phillips AA, Mayer SA, Singh AD, Soave R, Rossi A, Small CB, Walsh TJ, Rennert H, Shore TB.

Leuk Lymphoma. 2019 Jul;60(7):1693-1696. doi: 10.1080/10428194.2018.1543877. Epub 2019 Feb 10.

PMID:
30741059
4.

Breakthrough cytomegalovirus pneumonia in hematopoietic stem cell transplant recipient on letermovir prophylaxis.

Knoll BM, Seiter K, Phillips A, Soave R.

Bone Marrow Transplant. 2019 Jun;54(6):911-912. doi: 10.1038/s41409-018-0389-9. Epub 2018 Nov 6. No abstract available.

PMID:
30401966
5.

Incidence, significance, and persistence of human coronavirus infection in hematopoietic stem cell transplant recipients.

Eichenberger EM, Soave R, Zappetti D, Small CB, Shore T, van Besien K, Douglass C, Westblade LF, Satlin MJ.

Bone Marrow Transplant. 2019 Jul;54(7):1058-1066. doi: 10.1038/s41409-018-0386-z. Epub 2018 Nov 1.

6.

Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients.

Satlin MJ, Chavda KD, Baker TM, Chen L, Shashkina E, Soave R, Small CB, Jacobs SE, Shore TB, van Besien K, Westblade LF, Schuetz AN, Fowler VG Jr, Jenkins SG, Walsh TJ, Kreiswirth BN.

Clin Infect Dis. 2018 Nov 13;67(11):1720-1728. doi: 10.1093/cid/ciy363.

7.

Mycobacterial spindle cell pseudotumour: epidemiology and clinical outcomes.

Sfeir MM, Schuetz A, Van Besien K, Borczuk AC, Soave R, Jenkins SG, Walsh TJ, Small CB.

J Clin Pathol. 2018 Jul;71(7):626-630. doi: 10.1136/jclinpath-2017-204777. Epub 2018 Jan 24. Review.

PMID:
29367301
8.

So Many Possibilities: Lung Nodules in a Transplant Recipient.

Sfeir M, Douglass E, Soave R.

Am J Med. 2017 May;130(5):534-536. doi: 10.1016/j.amjmed.2016.12.013. Epub 2017 Jan 10. No abstract available.

PMID:
28082166
9.

Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies.

Satlin MJ, Cohen N, Ma KC, Gedrimaite Z, Soave R, Askin G, Chen L, Kreiswirth BN, Walsh TJ, Seo SK.

J Infect. 2016 Oct;73(4):336-45. doi: 10.1016/j.jinf.2016.07.002. Epub 2016 Jul 9.

10.

Implementation of Molecular Surveillance After a Cluster of Fatal Toxoplasmosis at 2 Neighboring Transplant Centers.

Isa F, Saito K, Huang YT, Schuetz A, Babady NE, Salvatore S, Pessin M, van Besien K, Perales MA, Giralt S, Sepkowitz K, Papanicolaou GA, Soave R, Kamboj M.

Clin Infect Dis. 2016 Aug 15;63(4):565-8. doi: 10.1093/cid/ciw330. Epub 2016 May 19.

11.

DAS181 for Treatment of Parainfluenza Virus Infections in Hematopoietic Stem Cell Transplant Recipients at a Single Center.

Salvatore M, Satlin MJ, Jacobs SE, Jenkins SG, Schuetz AN, Moss RB, Van Besien K, Shore T, Soave R.

Biol Blood Marrow Transplant. 2016 May;22(5):965-70. doi: 10.1016/j.bbmt.2016.02.011. Epub 2016 Feb 22.

12.

Klebsiella pneumoniae Isolate from a New York City Hospital Belonging to Sequence Type 258 and Carrying blaKPC-2 and blaVIM-4.

Castanheira M, Deshpande LM, Mills JC, Jones RN, Soave R, Jenkins SG, Schuetz AN.

Antimicrob Agents Chemother. 2016 Jan 4;60(3):1924-7. doi: 10.1128/AAC.01844-15.

13.

Clinical and molecular epidemiology of human rhinovirus infections in patients with hematologic malignancy.

Jacobs SE, Lamson DM, Soave R, Guzman BH, Shore TB, Ritchie EK, Zappetti D, Satlin MJ, Leonard JP, van Besien K, Schuetz AN, Jenkins SG, George KS, Walsh TJ.

J Clin Virol. 2015 Oct;71:51-8. doi: 10.1016/j.jcv.2015.07.309. Epub 2015 Jul 29.

14.

Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.

Satlin MJ, Vardhana S, Soave R, Shore TB, Mark TM, Jacobs SE, Walsh TJ, Gergis U.

Biol Blood Marrow Transplant. 2015 Oct;21(10):1808-14. doi: 10.1016/j.bbmt.2015.06.017. Epub 2015 Jul 3.

15.

Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens.

Corzo-León DE, Satlin MJ, Soave R, Shore TB, Schuetz AN, Jacobs SE, Walsh TJ.

Mycoses. 2015 Jun;58(6):325-36. doi: 10.1111/myc.12318. Epub 2015 Mar 24.

PMID:
25808822
16.

The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients.

Satlin MJ, Soave R, Racanelli AC, Shore TB, van Besien K, Jenkins SG, Walsh TJ.

Leuk Lymphoma. 2014 Dec;55(12):2858-65. doi: 10.3109/10428194.2014.896007. Epub 2014 Mar 24.

17.

Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies.

Satlin MJ, Calfee DP, Chen L, Fauntleroy KA, Wilson SJ, Jenkins SG, Feldman EJ, Roboz GJ, Shore TB, Helfgott DC, Soave R, Kreiswirth BN, Walsh TJ.

Leuk Lymphoma. 2013 Apr;54(4):799-806. doi: 10.3109/10428194.2012.723210. Epub 2012 Sep 14.

PMID:
22916826
18.

A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial.

Maki DG, Ash SR, Winger RK, Lavin P; AZEPTIC Trial Investigators.

Crit Care Med. 2011 Apr;39(4):613-20. doi: 10.1097/CCM.0b013e318206b5a2.

PMID:
21200319
19.

A care coordination program for substance-exposed newborns.

Twomey JE, Caldwell D, Soave R, Fontaine LA, Lester BM.

Child Welfare. 2011;90(5):115-33.

PMID:
22533057
20.

Vulnerable infants program of Rhode Island: promoting permanency for substance-exposed infants.

Twomey JE, Caldwell D, Soave R, Fontaine LA, Lester BM.

Child Welfare. 2010;89(3):121-42.

PMID:
20945808

Supplemental Content

Loading ...
Support Center